Dinoprostone is a naturally occurring prostaglandin E2 (PGE2). It has important effects in labour. It also stimulates osteoblasts to release factors which stimualtes bone resorption by osteoclasts. As a prescription drug it is used as a vaginal suppository, to prepare the cervix for labour and to induce labour.
For the termination of pregnancy during the second trimester (from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period), as well as for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first d...
NWAFH, North west Armed Forces Hospital, Tabuk, Saudi Arabia
Zekai Tahir Burak Women Health Education Research Hospital, Ankara, Turkey
Danish Headache Center, Glostrup, Denmark
Hospital Maternidade Leonor Mendes de Barros, São Paulo, Brazil
Hospital M Boi Mirim, São Paulo, Brazil
Hospital Municipal Universitário - Faculdade de Medicina do ABC, São Bernardo, São Paulo, Brazil
Liverpool Women's NHS Foundation Trust, Liverpool, Merseyside, United Kingdom
Olympe de Gouges Women Health Centre, Bretonneau University Hospital, Tours, France
New York Hospital Medical Center of Queens, Flushing, New York, United States
The Brooklyn Hospital Center, Brooklyn, New York, United States
Weill Medical College of Cornell University, New York, New York, United States
Shariaty Maternity Hospital, Tehran, Iran, Islamic Republic of
Danish Headache Center, Glostrup, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.